Stocks and Investing Stocks and Investing
Thu, May 4, 2023

Serge Belanger Reiterated (BCRX) at Strong Buy and Held Target at $14 on, May 4th, 2023


Published on 2024-10-28 03:22:06 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Reiterated "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy and Held Target at $14 on, May 4th, 2023.

Serge has made no other calls on BCRX in the last 4 months.



There are 3 other peers that have a rating on BCRX. Out of the 3 peers that are also analyzing BCRX, 0 agree with Serge's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Serge


  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $10 on, Thursday, April 20th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $30 on, Wednesday, February 22nd, 2023
  • Jonathan Wolleben of "JMP Securities" Reiterated at Buy and Held Target at $16 on, Wednesday, February 22nd, 2023
Contributing Sources